Silver Book Fact

Unplanned Hospital Readmissions & Costs Following Sepsis Hospitalizations

Among 187,697 hospital admissions for medical reasons that were associated with an unplanned 30-day readmission,  147,084 had a diagnosis of sepsis, 15,001 had a diagnosis of AMI, 79,480 were diagnosed with heart failure, 54,396 were diagnosed with COPD, and 59,378 were diagnosed with pneumonia.

The estimated mean cost per readmission was highest for sepsis ($10,070) compared with the other diagnoses including COPD ($8,417),  heart failure ($9,051), AMI ($9,424), and pneumonia ($9533).

Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions. Journal of American Medical Association Web site. http://jamanetwork.com/journals/jama/fullarticle/2598785. Published January 22 2017. Accessed January 27, 2017

Reference

Title
Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions
Publication
Journal of American Medical Association
Publication Date
Published January 22 2017
Authors
Chang C, Fine M, Yende S, Balakumar V, et al. V
URL
Read Full Resource

Categories

  • Economic Burden

Related Facts

  • Sepsis accounts for nearly 1/2 of ICU expenditures
    Infection and related sepsis/septicemia account for 40% of all ICU expenditures.  
  • Shingles causes an average of 129 hours lost work per episode
    Patients with shingles (including those progressing to postherpetic neuralgia) lose an average of over 129 hours of work per episode, including losses of 12 or more hours of work time  
  • Drug-resistant MRSA expensive to treat
    As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.  
  • Around $35 billion cost to society from antibiotic resistant infections
    The societal costs of antibiotic resistant infections are around $35 billion each year- this includes the cost of lost wages and premature deaths.  
  • Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually
    Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.